AU2018209127B2 - Media and methods for enhancing the survival and proliferation of stem cells - Google Patents

Media and methods for enhancing the survival and proliferation of stem cells Download PDF

Info

Publication number
AU2018209127B2
AU2018209127B2 AU2018209127A AU2018209127A AU2018209127B2 AU 2018209127 B2 AU2018209127 B2 AU 2018209127B2 AU 2018209127 A AU2018209127 A AU 2018209127A AU 2018209127 A AU2018209127 A AU 2018209127A AU 2018209127 B2 AU2018209127 B2 AU 2018209127B2
Authority
AU
Australia
Prior art keywords
acid
stem cells
lipid
culture medium
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018209127A
Other languages
English (en)
Other versions
AU2018209127A1 (en
Inventor
Wing CHANG
Michael Hiatt
Adam HIRST
Arwen HUNTER
Eric Jervis
Melanie KARDEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stemcell Technologies Canada Inc
Original Assignee
Stemcell Technologies Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62907538&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2018209127(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stemcell Technologies Canada Inc filed Critical Stemcell Technologies Canada Inc
Publication of AU2018209127A1 publication Critical patent/AU2018209127A1/en
Application granted granted Critical
Publication of AU2018209127B2 publication Critical patent/AU2018209127B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2018209127A 2017-01-23 2018-01-23 Media and methods for enhancing the survival and proliferation of stem cells Active AU2018209127B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762449413P 2017-01-23 2017-01-23
US62/449,413 2017-01-23
US201762518776P 2017-06-13 2017-06-13
US62/518,776 2017-06-13
US201762608875P 2017-12-21 2017-12-21
US62/608,875 2017-12-21
PCT/CA2018/050076 WO2018132926A1 (en) 2017-01-23 2018-01-23 Media and methods for enhancing the survival and proliferation of stem cells

Publications (2)

Publication Number Publication Date
AU2018209127A1 AU2018209127A1 (en) 2019-08-08
AU2018209127B2 true AU2018209127B2 (en) 2021-10-21

Family

ID=62907538

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018209127A Active AU2018209127B2 (en) 2017-01-23 2018-01-23 Media and methods for enhancing the survival and proliferation of stem cells

Country Status (9)

Country Link
US (2) US11697796B2 (https=)
EP (2) EP4361256A3 (https=)
JP (1) JP7049347B2 (https=)
CN (1) CN110462025B (https=)
AU (1) AU2018209127B2 (https=)
CA (1) CA3051141C (https=)
IL (1) IL268194B (https=)
SG (1) SG11201906731XA (https=)
WO (1) WO2018132926A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11697796B2 (en) 2017-01-23 2023-07-11 Stemcell Technologies Canada Inc. Media and methods for enhancing the survival and proliferation of stem cells
CN111808797A (zh) * 2020-07-28 2020-10-23 湖南赛诺生物科技股份有限公司 Necrostatin-1的应用及促进新生猪胰岛细胞成熟的制剂
JP2022032793A (ja) * 2020-08-14 2022-02-25 アルブキュラ コーポレーション アルブミン組成物並びにそれを製造及び使用する方法
AU2021337864A1 (en) 2020-09-02 2023-05-04 Yztherapeutic Performance Ltd. Cellular composition for treatment of diseases, disorders or conditions and method of use
WO2022114724A1 (ko) * 2020-11-27 2022-06-02 (주)엑셀세라퓨틱스 고효율 및 고순도 엑소좀 생산용 배지 조성물
CN116867892A (zh) * 2021-02-15 2023-10-10 凸版印刷株式会社 三维组织体的制造方法和脂肪来源干细胞的分化促进方法
CN116121186A (zh) * 2023-01-03 2023-05-16 内蒙古奥普赛生物科技有限公司 一种利用棕榈油酸培养脂肪间充质干细胞的方法
EP4698630A1 (en) * 2023-04-20 2026-02-25 Stemcell Technologies Canada Inc. Methods for large scale expansion of pluripotent stem cells (pscs)
CN116814532B (zh) * 2023-07-10 2025-02-11 上海迈邦生物科技有限公司 一种用于哺乳动物细胞培养基的脂类复合物及其制备方法与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2981277A1 (en) * 2015-03-30 2016-10-06 Ajinomoto Co., Inc. Human serum albumin-containing culture medium for growth of neural stem cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2277278A1 (en) 1997-01-10 1998-07-16 Life Technologies, Inc. Embryonic stem cell serum replacement
ATE549395T1 (de) 2004-09-08 2012-03-15 Wisconsin Alumni Res Found Medium und kultur von embryonalen stammzellen
US9074176B2 (en) * 2006-01-13 2015-07-07 Two Cells Co., Ltd. Culture medium additive for use in serum-free culturing of animal cell, kit and use thereof
US8241908B2 (en) 2006-05-16 2012-08-14 Becton, Dickinson And Company Extracellular matrix coated surface for culturing cells
GB0613756D0 (en) 2006-07-12 2006-08-23 Univ Sheffield Cell culture medium
ES2360782B1 (es) 2009-07-28 2012-03-12 Grifols, S.A. Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos.
FI20096288A0 (fi) 2009-12-04 2009-12-04 Kristiina Rajala Formulations and methods for culturing stem cells
CA2786331C (en) 2010-01-06 2018-05-01 Ervin Industries, Inc. Frangible, ceramic-metal composite objects and methods of making the same
JP6148429B2 (ja) 2011-01-31 2017-06-14 協和発酵バイオ株式会社 ヒト多能性幹細胞の培養方法
US8497124B2 (en) * 2011-12-05 2013-07-30 Factor Bioscience Inc. Methods and products for reprogramming cells to a less differentiated state
CA2866590A1 (en) 2012-03-07 2013-09-12 Janssen Biotech, Inc. Defined media for expansion and maintenance of pluripotent stem cells
CN105531365A (zh) * 2013-04-23 2016-04-27 耶达研究及发展有限公司 分离的幼稚多能干细胞和产生所述细胞的方法
SG11201509767UA (en) 2013-05-30 2015-12-30 Ajinomoto Kk Medium for culturing stem cells
WO2015042356A1 (en) 2013-09-19 2015-03-26 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Chemically defined culture medium for stem cell maintenance and differentiation
US11697796B2 (en) 2017-01-23 2023-07-11 Stemcell Technologies Canada Inc. Media and methods for enhancing the survival and proliferation of stem cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2981277A1 (en) * 2015-03-30 2016-10-06 Ajinomoto Co., Inc. Human serum albumin-containing culture medium for growth of neural stem cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FURUE, MK et al., "Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium", Proc Natl Acad Sci USA., (2008-09-09), vol. 105, ISSN 0027-8424, pages 13409 - 13414 *

Also Published As

Publication number Publication date
AU2018209127A1 (en) 2019-08-08
IL268194B (en) 2022-05-01
CN110462025A (zh) 2019-11-15
US20200017825A1 (en) 2020-01-16
SG11201906731XA (en) 2019-08-27
US20230250392A1 (en) 2023-08-10
EP3571290A4 (en) 2020-10-28
CA3051141A1 (en) 2018-07-26
EP3571290B1 (en) 2024-04-10
CA3051141C (en) 2021-06-22
JP7049347B2 (ja) 2022-04-06
IL268194A (en) 2019-09-26
EP3571290A1 (en) 2019-11-27
US11697796B2 (en) 2023-07-11
CN110462025B (zh) 2023-11-21
JP2020505038A (ja) 2020-02-20
EP4361256A3 (en) 2024-07-31
WO2018132926A1 (en) 2018-07-26
EP4361256A2 (en) 2024-05-01

Similar Documents

Publication Publication Date Title
US20230250392A1 (en) Media and methods for enhancing the survival and proliferation of stem cells
CN102791276B (zh) 含有间充质干细胞的细胞制品及其制造方法
CN1871343B (zh) 从脂肪组织制备干细胞的方法和系统
JP6662777B2 (ja) 人工心筋（ｅｈｍ）を産生するための方法
CN105838676B (zh) 一种用于视网膜色素上皮细胞的培养液及其制备方法和应用
JP2012175962A (ja) ヒト多能性幹細胞の培養方法
Sardesai et al. Avoidance of maternal cell contamination and overgrowth in isolating fetal chorionic villi mesenchymal stem cells from human term placenta
EP3963050B1 (en) Preparation of human allogeneic liver-derived progenitor cells
CN115997005A (zh) 间充质谱系前体或干细胞的3d培养
US11697798B2 (en) Enhanced differentiation and maturation of pluripotent stem cell-derived myogenic cells
US20220220445A1 (en) Preparation of human allogeneic liver-derived progenitor cells
HK40110808A (en) Media and methods for enhancing the survival and proliferation of stem cells
HK40017314B (en) Media and methods for enhancing the survival and proliferation of stem cells
HK40017314A (en) Media and methods for enhancing the survival and proliferation of stem cells
Yao et al. Effect of various ratios of co‐cultured ATDC5 cells and chondrocytes on the expression of cartilaginous phenotype in microcavitary alginate hydrogel
JP2016073323A (ja) ヒト多能性幹細胞の培養方法
US20230113074A1 (en) Derivation of hepatocytes and hematopoietic progenitors from human embryonic stem cells
Liu et al. Development of a biodegradable smooth-surface microcarrier for retinal pigment epithelial cell expansion and maturation
JP2025535110A (ja) 新規の細胞株および治療におけるそれらの使用
CN116355836A (zh) 胆管树干细胞的扩增或传代体系及其应用
HK1226443A1 (en) Method for producing engineered heart muscle (ehm)
CN120442545A (zh) 一种用于脑类器官分化的基质胶及其制备方法和应用
CN117858704A (zh) 细胞接种剂和细胞移植用基材
HK40068803B (en) Preparation of human allogeneic liver-derived progenitor cells
HK40068803A (en) Preparation of human allogeneic liver-derived progenitor cells

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)